A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line
- 1 November 1988
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 156 (3), 1383-1389
- https://doi.org/10.1016/s0006-291x(88)80785-x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Pathways of Ca2+ influx at the plasma membrane: Voltage-, receptor-, and second messenger-operated channelsExperimental Cell Research, 1987
- Effects of bombesin and insulin on inositol (1,4,5) trisphosphate and inositol (1,3,4) trisphosphate formation in Swiss 3T3 cellsCell, 1986
- Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. II. Changes in Na+ and Ca2+ fluxes, Na+/K+ pump activity, and intracellular pH.The Journal of cell biology, 1986
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985
- I. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancerLife Sciences, 1985
- Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro.JCI Insight, 1985
- Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cellsExperimental Cell Research, 1984
- Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glandsBiochemical Journal, 1982
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973